BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kadamb R, Leibovitch BA, Farias EF, Dahiya N, Suryawanshi H, Bansal N, Waxman S. Invasive phenotype in triple negative breast cancer is inhibited by blocking SIN3A-PF1 interaction through KLF9 mediated repression of ITGA6 and ITGB1. Transl Oncol 2021;16:101320. [PMID: 34968869 DOI: 10.1016/j.tranon.2021.101320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Olivet J, Choi SG, Sierra S, O’grady TM, de la Fuente Revenga M, Laval F, Botchkarev VV, Gorgulla C, Coote PW, Blavier J, Geffken EA, Lakhani J, Song K, Yeoh ZC, Hu B, Varca AC, Bruyr J, Ibrahim S, Jivanjee T, Bromley JD, Nyquist SK, Richardson A, Yue H, Wang Y, Calonghi N, Stefan A, Spirohn K, Vertommen D, Baietti MF, Lemmens I, Seo H, Dozmorov MG, Willems L, Tavernier J, Das K, Leucci E, Hochkoeppler A, Sun ZJ, Calderwood MA, Hao T, Shalek AK, Hill DE, Boeszoermenyi A, Arthanari H, Buhrlage SJ, Dhe-paganon S, González-maeso J, Dequiedt F, Twizere J, Vidal M. Expanding the HDAC druggable landscape beyond enzymatic inhibition.. [DOI: 10.1101/2022.12.07.519454] [Reference Citation Analysis]
2 Dahiya NR, Leibovitch BA, Kadamb R, Bansal N, Waxman S. The Sin3A/MAD1 Complex, through Its PAH2 Domain, Acts as a Second Repressor of Retinoic Acid Receptor Beta Expression in Breast Cancer Cells. Cells 2022;11:1179. [DOI: 10.3390/cells11071179] [Reference Citation Analysis]